The World Health Organization (WHO) warned this week that the pandemic was not even close to being over, but in the Czech Republic, a party has been held to give the coronavirus a "symbolic farewell".
Gilead Sciences Inc has priced its COVID-19 drug candidate remdesivir at $2,340 for a five-day treatment in the United States and some other developed countries, potentially reflecting looming competition from a cheap steroid.
Bharat Biotech's COVID-19 vaccine has been approved for human trials, making it India's first domestic candidate to get the green light from the government's drug regulator as cases surge in a country with more than 1.3 billion people.
Malawi's electoral commission has declared opposition alliance leader Lazarus Chakwera the winner of the country's presidential election rerun.
Authorities were investigating a fatal shooting on Saturday night at a park in the US state of Kentucky, where anti-racism demonstrators had gathered to protest against the death of a Black woman, Breonna Taylor.
More Articles …
- Pressured by growing ad boycott, Facebook will label posts
- Idris Elba, Viola Davis and Queen Latifah among 300 black artists and execs pushing Hollywood to change
- Coronavirus: New York imposes quarantine on eight US states
- Human trials for coronavirus vaccine start in South Africa
Page 18 of 53
